Mo and Zn-Dual doped CuxO nanocrystals confined High-Conductive Cu arrays as novel sensitive sensor for neurotransmitter detection.

The development of sensitive and selective sensors using facile and low-cost methods for detecting neurotransmitter molecules is a critical factor in the health care system in regard to early diagnosis. In this research, an electrocatalyst derived from Mo,Zn dual-doped CuxO nanocrystals-based layer coating over one-dimensional copper nanowire arrays (Mo,Zn-CuxO/CuNWs) was successfully designed using a facile electrodeposition approach and used as an electrochemical sensor for non-enzymatic dopamine (DA) neurotransmitter detection. The synergistic effect caused by the dual-doping effect along with its excellent conductivity produced a large electroactive surface area and an improved hetero-charge transfer, thereby boosting DA sensing ability with a low limit detection of 0.32 µM, wide-range of detection (0.5 µM - 3.9 mM), long-term stability (5 weeks), and high selectivity in phosphate buffer solution (pH 7.4). Also, the sensor accurately determined DA in real blood serum-spiked solutions. The achieved results evidenced that the Mo,Zn-CuxO/CuNWs derived sensor is highly suitable for DA detection. Therefore, it also opens new windows for the development of low-cost, accurate, high-performance, and stable sensors for other neurotransmitter sensing for the purposes of better health care and early diagnosis.

Cu-Au nanocrystals functionalized carbon nanotube arrays vertically grown on carbon spheres for highly sensitive detecting cancer biomarker.

A three-dimensional hierarchical nanohybrid based on Cu-Au bimetallic nanocrystals integrated carbon nanotube arrays vertically grown on carbon spheres was successfully developed as an active platform for sensing application. Such nanohybrid can provide abundant active sites and act as an exceptional platform for immobilizing highly dense and well-dispersed carcinoembryonic antibody (anti-CEA) to sensitively detect CEA, an emerging biomarker of various cancer diseases. Due to the unique nanoarchitecture with altered electronic structure of Cu-Au bimetallic catalyst and enhanced interactions between components, such nanohybrid based biosensor demonstrated excellent electrochemical performance towards CEA detection with great sensitivity, wide linear detection range (0.025-25 ng/mL), very low limit of detection (0.5 pg/mL), and good selectivity. The results imply that this sensor has great potential to offer essential information for cancer diagnosis and management with great clinical importance.